Collecting and storing tissue samples from patients with suspected solid tumors
Official title: Advanced Tumor Bank Project
Run by Wake Forest University Health Sciences · NCT00900471 · Data updated 2026-11-12
This study is collecting blood and tissue samples from patients with suspected solid tumors to help with future cancer research and understand how normal tissue changes to cancerous tissue.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | April 1, 2004 |
| Main results expected | May 2027 |
| Study ends | May 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT00900471 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with clinically suspected solid tumors who are scheduled for surgical resection or biopsy.
✕Probably not a fit
Patients who do not have a suspected solid tumor or are not undergoing surgery or biopsy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research focuses on collecting and preserving blood and tissue samples from patients undergoing surgery for suspected solid tumors. The samples will be used to create a repository for future cancer research at Wake Forest University Comprehensive Cancer Center. The study aims to analyze changes from normal to cancerous tissue and may involve genetic analysis of the tumor samples. Information about patients' medical histories will also be collected to support ongoing research efforts.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of cancer biology and improve future treatment strategies.
How similar studies have gone: Other studies involving tissue sample collection for cancer research have shown success in advancing our understanding of tumor biology and treatment options.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed protocol specific informed consent prior to registration/randomization. * Clinically suspected solid tumor AND scheduled for surgical resection and/or biopsy
Where it's running
-
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Study Coordinator
- Email: Sarah.Davis@advocatehealth.org
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing CP-506 for treating advanced solid tumors
This study is testing a new drug called CP-506 to see if it can help people with advanced solid tumors, especially those with specific DNA repair issues, by trying it alone and with other treatments.
-
Personalized treatment for advanced solid tumors using tumor genetics and expression profiling
This study tests whether a patient’s tumor genetics and gene expression can guide personalized treatment choices for adults with advanced solid tumors.
-
Using genomic profiling to recommend cancer treatment for patients with metastatic tumors
This study tests if analyzing the DNA of metastatic tumors can help doctors recommend better treatments for cancer patients.
-
Registry of older patients with cancer
This study collects health information from older cancer patients to create a registry that helps improve care and research for seniors with cancer.
-
Collecting tissue samples from cancer patients and healthy participants
This study is collecting tissue samples from cancer patients receiving radiation therapy and healthy individuals to see how genetic differences affect treatment outcomes and to build a resource for future research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.